Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications
LP-118 is a novel B-cell lymphoma 2 / extra-large inhibitor that demonstrates efficacy in models of venetoclaxresistant chronic lymphocytic leukemia.
Journal: Haematologica
Published: October 11, 2023
Dual Targeting of Apoptotic and Signaling Pathways in T-Lineage Acute Lymphoblastic Leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: February 10, 2023
CSF1 receptor inhibition of tenosynovial giant cell tumor using novel disease-specific MRI measures of tumor burden.
Journal: Future oncology (London, England)
Published: January 18, 2022
A prospective biomarker analysis of alvocidib followed by cytarabine and mitoxantrone in MCL-1-dependent relapsed/refractory acute myeloid leukemia.
Journal: Blood cancer journal
Published: August 17, 2021
Results from Phase I Extension Study Assessing Pexidartinib Treatment in Six Cohorts with Solid Tumors including TGCT, and Abnormal CSF1 Transcripts in TGCT.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: June 09, 2021
Multi-omic molecular profiling guide's efficacious treatment selection in refractory metastatic breast cancer: a prospective phase II clinical trial.
Journal: Molecular oncology
Published: March 16, 2021
Phase I Study of Alvocidib Followed by 7+3 (Cytarabine + Daunorubicin) in Newly Diagnosed Acute Myeloid Leukemia.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: July 06, 2020
Pharmacokinetics of carfilzomib in patients with advanced malignancies and varying degrees of hepatic impairment: an open-label, single-arm, phase 1 study.
Journal: Experimental hematology & oncology
Published: July 25, 2017
Safety and Pharmacokinetics of Bendamustine Rapid-Infusion Formulation.
Journal: Journal of clinical pharmacology
Published: November 15, 2016
Enrichment of PI3K-AKT-mTOR Pathway Activation in Hepatic Metastases from Breast Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 21, 2016
Patient-reported Symptoms of Tenosynovial Giant Cell Tumors.
Journal: Clinical therapeutics
Published: December 29, 2015
A multicenter, open-label, Phase 1 study evaluating the safety and tolerability of pegaspargase in combination with gemcitabine in advanced metastatic solid tumors and lymphoma.
Journal: Cancer investigation
Published: April 07, 2015
Last Updated: 09/26/2026